Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker INCY
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Steven H. Stein CMO & Head of Late-Stage Dev. | INCY Incyte Corporation | Sale | 48,576 | $119.66 | $5.8M Sale | Form 4 ↗ |
| Nov 6, 2026 | Steven H. Stein CMO & Head of Late-Stage Dev. | INCY Incyte Corporation | Sale | 73,969 | $119.12 | $8.8M Sale | Form 4 ↗ |
| Nov 6, 2026 | Steven H. Stein CMO & Head of Late-Stage Dev. | INCY Incyte Corporation | Sale | 60,270 | $118.27 | $7.1M Sale | Form 4 ↗ |
| Nov 6, 2026 | Steven H. Stein CMO & Head of Late-Stage Dev. | INCY Incyte Corporation | Sale | 22,336 | $117.15 | $2.6M Sale | Form 4 ↗ |
| Nov 6, 2026 | Steven H. Stein CMO & Head of Late-Stage Dev. | INCY Incyte Corporation | Sale | 35,042 | $116.06 | $4.1M Sale | Form 4 ↗ |
| Nov 3, 2026 | Thomas Tray Principal Accounting Officer | INCY Incyte Corporation | Sale | 610 | $118.96 | $72.6K Sale | Form 4 ↗ |
| Oct 15, 2026 | Pablo J. Cagnoni President, Global Head of R&D | INCY Incyte Corporation | Sale | 2,642 | $112.71 | $297.8K Sale | Form 4 ↗ |
| Sep 15, 2026 | Pablo J. Cagnoni President, Global Head of R&D | INCY Incyte Corporation | Sale | 13,985 | $120.49 | $1.7M Sale | Form 4 ↗ |
| Sep 15, 2026 | Pablo J. Cagnoni President, Global Head of R&D | INCY Incyte Corporation | Sale | 9,233 | $120.50 | $1.1M Sale | Form 4 ↗ |
| Aug 19, 2026 | Pablo J. Cagnoni President, Global Head of R&D | INCY Incyte Corporation | Sale | 10,801 | $125.56 | $1.4M Sale | Form 4 ↗ |
| Aug 12, 2026 | Pablo J. Cagnoni President, Global Head of R&D | INCY Incyte Corporation | Sale | 10,803 | $120.04 | $1.3M Sale | Form 4 ↗ |
| Aug 5, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 2,207 | $123.99 | $273.6K Sale | Form 4 ↗ |
| Aug 5, 2026 | Pablo J. Cagnoni President, Global Head of R&D | INCY Incyte Corporation | Sale | 10,640 | $122.69 | $1.3M Sale | Form 4 ↗ |
| Aug 3, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 6,055 | $120.43 | $729.2K Sale | Form 4 ↗ |
| Jul 31, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 2,293 | $119.41 | $273.8K Sale | Form 4 ↗ |
| Jul 31, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 326 | $121.69 | $39.7K Sale | Form 4 ↗ |
| Jul 31, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 85 | $122.19 | $10.4K Sale | Form 4 ↗ |
| Jul 31, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 1,642 | $119.38 | $196.0K Sale | Form 4 ↗ |
| Jul 31, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 1,643 | $119.51 | $196.4K Sale | Form 4 ↗ |
| Jul 31, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 2,864 | $119.40 | $342.0K Sale | Form 4 ↗ |
| Jul 31, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 4,695 | $119.39 | $560.5K Sale | Form 4 ↗ |
| Jul 31, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 6,171 | $119.43 | $737.0K Sale | Form 4 ↗ |
| Jul 31, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 2,187 | $119.47 | $261.3K Sale | Form 4 ↗ |
| Jul 31, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 5,332 | $119.42 | $636.7K Sale | Form 4 ↗ |
| Jul 31, 2026 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 14,661 | $119.46 | $1.8M Sale | Form 4 ↗ |
| Jul 31, 2026 | Pablo J. Cagnoni President, Global Head of R&D | INCY Incyte Corporation | Sale | 15,888 | $119.70 | $1.9M Sale | Form 4 ↗ |
| Jul 16, 2026 | Mohamed Khairie Issa EVP, Head of U.S. Commercial | INCY Incyte Corporation | Sale | 1,093 | $115.01 | $125.7K Sale | Form 4 ↗ |
| Jul 16, 2026 | Steven H. Stein CMO & Head of Late-Stage Dev. | INCY Incyte Corporation | Sale | 1,877 | $114.73 | $215.3K Sale | Form 4 ↗ |
| Jul 15, 2026 | Steven H. Stein CMO & Head of Late-Stage Dev. | INCY Incyte Corporation | Sale | 28,237 | $113.05 | $3.2M Sale | Form 4 ↗ |
| Jun 4, 2026 | Thomas Tray Principal Accounting Officer | INCY Incyte Corporation | Sale | 2,639 | $100.00 | $263.9K Sale | Form 4 ↗ |
| May 26, 2026 | Thomas Tray Principal Accounting Officer | INCY Incyte Corporation | Sale | 2,051 | $97.35 | $199.7K Sale | Form 4 ↗ |
| May 19, 2026 | Paul J. Clancy Director | INCY Incyte Corporation | Sale | 15,000 | $94.93 | $1.4M Sale | Form 4 ↗ |
| Apr 17, 2026 | Pablo J. Cagnoni President, Global Head of R&D | INCY Incyte Corporation | Sale | 18,667 | $96.50 | $1.8M Sale | Form 4 ↗ |
| Mar 17, 2026 | Pablo J. Cagnoni President, R&D | INCY Incyte Corporation | Sale | 18,667 | $94.24 | $1.8M Sale | Form 4 ↗ |
| Feb 19, 2026 | Pablo J. Cagnoni President, R&D | INCY Incyte Corporation | Sale | 18,668 | $100.91 | $1.9M Sale | Form 4 ↗ |
| Jan 7, 2026 | Mohamed Khairie Issa EVP, Head of US Oncology | INCY Incyte Corporation | Sale | 10,856 | $109.07 | $1.2M Sale | Form 4 ↗ |
| Jan 5, 2026 | Steven H. Stein EVP & Chief Medical Officer | INCY Incyte Corporation | Sale | 15,634 | $101.70 | $1.6M Sale | Form 4 ↗ |
| Dec 19, 2025 | Thomas Tray Principal Accounting Officer | INCY Incyte Corporation | Sale | 2,774 | $100.00 | $277.4K Sale | Form 4 ↗ |
| Dec 18, 2025 | Thomas Tray Principal Accounting Officer | INCY Incyte Corporation | Sale | 600 | $98.25 | $59.0K Sale | Form 4 ↗ |
| Dec 17, 2025 | Michael James Morrissey EVP, Head of Tech. Operations | INCY Incyte Corporation | Sale | 4,323 | $97.26 | $420.5K Sale | Form 4 ↗ |
| Dec 16, 2025 | Michael James Morrissey EVP, Head of Tech. Operations | INCY Incyte Corporation | Sale | 53,175 | $97.29 | $5.2M Sale | Form 4 ↗ |
| Dec 16, 2025 | Michael James Morrissey EVP, Head of Tech. Operations | INCY Incyte Corporation | Sale | 833 | $97.42 | $81.2K Sale | Form 4 ↗ |
| Dec 11, 2025 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 255 | $94.94 | $24.2K Sale | Form 4 ↗ |
| Dec 10, 2025 | Patrick A. Mayes EVP & Chief Scientific Officer | INCY Incyte Corporation | Sale | 5,553 | $95.58 | $530.8K Sale | Form 4 ↗ |
| Dec 2, 2025 | Steven H. Stein EVP & Chief Medical Officer | INCY Incyte Corporation | Sale | 20,105 | $102.51 | $2.1M Sale | Form 4 ↗ |
| Dec 1, 2025 | Steven H. Stein EVP & Chief Medical Officer | INCY Incyte Corporation | Sale | 2,559 | $102.96 | $263.5K Sale | Form 4 ↗ |
| Nov 24, 2025 | Thomas Tray Principal Accounting Officer | INCY Incyte Corporation | Sale | 600 | $103.00 | $61.8K Sale | Form 4 ↗ |
| Nov 21, 2025 | Thomas Tray Principal Accounting Officer | INCY Incyte Corporation | Sale | 169 | $102.00 | $17.2K Sale | Form 4 ↗ |
| Nov 17, 2025 | Sheila A. Denton EVP & General Counsel | INCY Incyte Corporation | Sale | 278 | $104.36 | $29.0K Sale | Form 4 ↗ |
| Nov 10, 2025 | Herve Hoppenot Director | INCY Incyte Corporation | Sale | 187,500 | $105.46 | $19.8M Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:18 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances